Have you dreamed of owning a residential property and to live by the sea, for years? Are you looking for investment options in tourist area land that will offer high short- or long-term returns? Are ...
Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journal ; Study met primary efficacy endpoint of improvement in nasa ...
Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, today announced that ...
“We are thrilled to see the detailed results from our pivotal Australian trial published in one the leading medical journals in allergology,” commented Thomas Meyer, Altamira’s ...
"Altamira emerged from the 2023 business year as a stronger and more focused company," commented Thomas Meyer, Altamira Therapeutics' founder, Chairman, and CEO. "We keep progressing with our RNA ...
The social and environmental impact of the Belo Monte dam and hydroelectric power plant in Pará state, Brazil, has been called a "disaster" by researchers, environmentalists and several media outlets.
Good morning, and welcome to the Altamira Therapeutics Business Update and Full Year 2023 Earnings Conference Call. On today's call are Thomas Meyer, Altamira's Founder, Chairman and the Chief ...
Altamira Therapeutics (CYTO) shares surge as positive results from the NASAR trial of their Bentrio nasal spray for allergic rhinitis are published.
HAMILTON, BERMUDA -- April 24, 2024 --Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and ...
Altamira Therapeutics Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Altamira ...
“We are thrilled to see the detailed results from our pivotal Australian trial published in one the leading medical journals in allergology,” commented Thomas Meyer, Altamira’s ...